Alberta collaborates with Janssen to progress early-stage technologies related to diabetes The Alberta Diabetes Institute at the University of Alberta has announced a new collaboration with Janssen Inc. In Canada to progress early-stage technologies related to Type I and Type II diabetes. Janssen can be area of the Janssen Pharmaceutical Companies of Johnson & Johnson. The Johnson & Johnson Diabetes Study Fund is usually a newly-created $600,000 partnership, funded between Janssen, the national government of Alberta, and the Alberta Diabetes Base. The three 12 months competitive fund, administered by U of A's Alberta Diabetes Institute, will support analysis in either Type I or Type II diabetes with a focus on novel, discovery study with a high potential for commercialization.Although Hindawi doesn’t allow authors recommend reviewers for his or her manuscripts, it made a decision to examine the peer-review records for manuscripts submitted in 2013 and 2014 for possible fraud. The peer-review procedure used in Hindawi’s journals depends primarily on the expertise of its editorial board members and the guest editors of special issues, who are responsible for supervising the overview of submitted manuscripts.5 Because the peer reviewers selected by the guest editors were not subject to any sort of independent verification, editors themselves could undermine the procedure in much the same way that authors or third-party agencies have done elsewhere: by creating fake reviewer identities and addresses that they submitted reviews that are positive endorsing publication.